Long-term follow-up of adalimumab monotherapy for rheumatoid arthritis in Japanese patients: a report of six cases

被引：0

作者：

Ichinose, Kunihiro ^{[1
]}

Origuchi, Tomoki ^{[2
]}

Kawashiri, Shin-ya ^{[1
]}

Iwamoto, Naoki ^{[1
]}

Fujikawa, Keita ^{[1
]}

Aramaki, Toshiyuki ^{[1
]}

Kamachi, Makoto ^{[1
]}

Arima, Kazuhiko ^{[1
]}

Tamai, Mami ^{[1
]}

Nakamura, Hideki ^{[1
]}

Ida, Hiroaki ^{[1
]}

Kawakami, Atsushi ^{[1
]}

Eguchi, Katsumi ^{[1
]}

机构：

[1] Nagasaki Univ, Dept Rheumatol, Unit Translat Med, Grad Sch Biomed Sci, Nagasaki 8528501, Japan

[2] Nagasaki Univ, Dept Phys Therapy, Unit Rehabil, Grad Sch Biomed Sci, Nagasaki 8528501, Japan

来源：

RHEUMATOLOGY INTERNATIONAL | 2012年 / 32卷 / 02期

关键词：

Rheumatoid arthritis (RA); Adalimumab; Long-term; DAS28-CRP; ANTITUMOR NECROSIS FACTOR; MONOCLONAL-ANTIBODY; METHOTREXATE; RISK; TUBERCULOSIS; EFFICACY; THERAPY; DISEASE; SAFETY;

D O I：

10.1007/s00296-010-1770-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We present six cases of patients with Japanese rheumatoid arthritis (RA) treated with a tumor necrosis factor (TNF)-alpha blocking agent, adalimumab as monotherapy for 220 weeks. All six patients were women, and the median age was 54.0 +/- A 7.07 years old. The median duration of the disease was 7.43 +/- A 11.1 years, and the median disease activity score (DAS28-CRP) was 5.35 +/- A 0.69. Three of six patients were able to continue to receive this treatment for 220 weeks successfully, and the DAS28-CRP decreased to 1.89 +/- A 0.75. Two patients withdrew because of lack of efficacy, and one patient withdrew because of adverse events (non-Hodgkin lymphoma). Adalimumab resulted in a sustained clinical response in RA patients during 220-week follow-up.

引用

页码：483 / 487

页数：5

共 50 条

[21] Long-term treatment response in rheumatoid arthritis patients starting adalimumab or etanercept with or without concomitant methotrexate
l'Ami, M. J.
Kneepkens, E. L.
Nurmohamed, M. T.
Krieckaert, C. L. M.
Visman, I. M.
Wolbink, G. J.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (03) : 431 - 437
[22] Long-term safety and effectiveness of adalimumab for the treatment of Japanese patients with rheumatoid arthritis: 3-year results from a postmarketing surveillance of 552 patients
Harigai, Masayoshi
Tsuchiya, Tsuyoshi
Kawana, Katsuyoshi
Kurimoto, Sarina
MODERN RHEUMATOLOGY, 2018, 28 (01) : 30 - 38
[23] Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: A long-term follow-up of predictors, surveillance, and outcome in clinical practice
Sundbaum, Johanna Karlsson
Eriksson, Niclas
Hallberg, Par
Lehto, Niklas
Wadelius, Mia
Baecklund, Eva
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2019, 22 (07) : 1226 - 1232
[24] Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: Postmarketing surveillance report of 7740 patients
Koike, Takao
Harigai, Masayoshi
Ishiguro, Naoki
Inokuma, Shigeko
Takei, Syuji
Takeuchi, Tsutomu
Yamanaka, Hisashi
Haruna, Shigenori
Ushida, Naoko
Kawana, Katsuyoshi
Tanaka, Yoshiya
MODERN RHEUMATOLOGY, 2014, 24 (03) : 390 - 398
[25] Long-Term Follow-Up of Patients with Hypoparathyroidism
Mitchell, Deborah M.
Regan, Susan
Cooley, Michael R.
Lauter, Kelly B.
Vrla, Michael C.
Becker, Carolyn B.
Burnett-Bowie, Sherri-Ann M.
Mannstadt, Michael
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (12): : 4507 - 4514
[26] The long-term follow-up of patients with endoscopically diagnosed reflux oesophagitis with specific emphasis to complaints
Loffeld, Susan M. L. A.
Dackus, Gwen M. H. E.
Loffeld, Ruud J. L. F.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2011, 23 (12) : 1122 - 1126
[27] Influence of selected demographic and clinical factors on the treatment of rheumatoid arthritis - a long-term follow-up
Kruszewski, Robert
Kisiel, Bartlomiej
Tlustochowicz, Witold
PEDIATRIA I MEDYCYNA RODZINNA-PAEDIATRICS AND FAMILY MEDICINE, 2021, 17 (02): : 142 - 147
[28] Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research
Salliot, C.
van der Heijde, D.
ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (07) : 1100 - 1104
[29] Follow-Up Results of Our Patients with Rheumatoid Arthritis
Yalcin, Tugba
Bal, Ajda
Dulgeroglu, Deniz
Cakci, Aytul
TURKISH JOURNAL OF RHEUMATOLOGY, 2012, 27 (02) : 98 - 108
[30] Long-term persistence with rituximab in patients with rheumatoid arthritis
Oldroyd, Alexander G. S.
Symmons, Deborah P. M.
Sergeant, Jamie C.
Kearsley-Fleet, Lianne
Watson, Kath
Lunt, Mark
Hyrich, Kimme L.
RHEUMATOLOGY, 2018, 57 (06) : 1089 - 1096

← 1 2 3 4 5 →